The U.S. government shutdown has stretched on another day and Congress is now dangerously close to not reopening the government prior to Thursday, the deadline to extend the debt ceiling. Prior to Tuesday, U.S. stocks had admirably dealt with the situation.
So have already resurgent Europe ETFs. That could be the result of the International Monetary Fund recently boosting its 2013 and 2014 growth outlooks for the once downtrodden Eurozone. Even the PIIGS have gotten in on the act.
Ireland’s economy has strengthened and is on track to wean itself off the Eurozone and International Monetary Fund bailout program, helping the iShares MSCI Ireland Capped ETF (EIRL) become one of 2013’s top-performing country-specific developed markets ETFs. [Ireland ETF Soars as Country Ditches Bailout]
“VGK appears to have hit bottom in late June. Since that time, VGK has catapulted 17% off its lows. It has also bounced higher off support levels at its 50-day trendline in late August as well as October,” writes Gary Gordon.
While the Eurozone is not entirely out of the woods, the outlook has improved to the point where some previously controversial European banking giants are poised to significantly increase their dividends. [Bank on Europe Bank Dividends With These ETFs]
In addition to considering European financials, investors may also want to have a look at the region’s small-caps with ETFs like the iShares MSCI EAFE Small-Cap ETF (SCZ).
SCZ “boast s a price-to-book of 2.85, dividend yield 2.75% as well as less beta volatility than the S&P 500. The current price is solidly above both a 50-day and a 200-day moving average. The 19% gains off of the June lows aren’t too shabby either,” wrote Gordon.
SCZ allocates over 49% of its combined weight to Japan and the U.K., but the ETF does have Eurozone exposure via Germany, France and Italy.
iShares MSCI EAFE Small-Cap ETF
ETF Trends editorial team contributed to this post.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.